BenevolentAI SA
AEX:BAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bajaj Hindusthan Sugar Ltd
NSE:BAJAJHIND
|
IN |
|
UMT United Mobility Technology AG
XETRA:UMDK
|
DE |
|
H
|
Hangzhou Flariant Co Ltd
SSE:605566
|
CN |
|
China Cinda Asset Management Co Ltd
HKEX:1359
|
CN |
BenevolentAI SA
EPS (Diluted)
BenevolentAI SA
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
BenevolentAI SA
AEX:BAI
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
EPS (Diluted)
£1
|
CAGR 3-Years
-28%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
AstraZeneca PLC
LSE:AZN
|
EPS (Diluted)
$6
|
CAGR 3-Years
46%
|
CAGR 5-Years
22%
|
CAGR 10-Years
11%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
EPS (Diluted)
$2
|
CAGR 3-Years
37%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
EPS (Diluted)
£0
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BenevolentAI SA
Glance View
BenevolentAI SA is a holding company that engages in the research and development and sale of AI-enabled drugs. The firm through the combined capabilities of its AI platform, scientific ability and wet-lab facilities deliver new drug candidates with a higher probability of clinical success than those developed using traditional methods. The company has an array of scientifically validated discoveries. The Company, through its BenevolentAI Platform, offers in-house pipeline of over 20 disease programs, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies, such as AstraZeneca, as well as other research and charitable institutions.
See Also
What is BenevolentAI SA's EPS (Diluted)?
EPS (Diluted)
-0.5
GBP
Based on the financial report for Dec 31, 2023, BenevolentAI SA's EPS (Diluted) amounts to -0.5 GBP.
What is BenevolentAI SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
64%
Over the last year, the EPS (Diluted) growth was 64%.